Alberto Risueno Perez

Title: Innovations by Alberto Risueno Perez

Introduction

Alberto Risueno Perez is a notable inventor based in Seville, Spain. He has made significant contributions to the field of medical research, particularly in the area of diffuse large B-cell lymphoma (DLBCL). With a total of 2 patents, his work focuses on methods for classifying and treating this type of lymphoma.

Latest Patents

Alberto's latest patents include innovative methods for predicting and treating DLBCL. One patent outlines a method of predicting if a subject has an Activated B Cell-like (ABC) subtype or a non-ABC subtype of DLBCL. This method involves obtaining a sample from the subject, measuring the expression levels of specific biomarkers, and determining a composite score to make predictions about the subtype. Another patent focuses on methods for predicting the responsiveness of DLBCL patients to treatments such as lenolidomide. This includes utilizing biomarkers that correlate with treatment responsiveness, thereby enhancing the effectiveness of therapeutic strategies.

Career Highlights

Alberto Risueno Perez is associated with Celgene Corporation, where he applies his expertise in oncology and biomarker research. His work has the potential to significantly impact patient outcomes in the treatment of DLBCL.

Collaborations

Alberto collaborates with esteemed colleagues, including Matthew William Burnell Trotter and Michael Pourdehnad. Their combined efforts contribute to advancing research in lymphoma treatment and classification.

Conclusion

Alberto Risueno Perez is a distinguished inventor whose work in the field of diffuse large B-cell lymphoma is paving the way for improved diagnostic and treatment methods. His contributions are vital to the ongoing fight against cancer, showcasing the importance of innovation in medical research.